Read more at MarketWatch.
‘In a worst-case scenario, we fear a stock-market bust’: We are ‘healthy boomers’ in our 60s with a net worth of $4.2 million. Is it time to diversify?
Date: |
Sort by
Filter
Date
-
MarketWatch - Business
We’re in our mid-50s and planning to retire soon. We have $2 million saved. How can we extract income from our $900,000 home?
“We have no children or heirs, and have no one to leave our estate to other than charitable causes.” -
MarketWatch - Business
My spouse and I are 60 and receive $145,000 a year in pensions. Do we need to worry about inflation killing our retirement plans?
“Our annual expenses are $105,000 and that includes travel, entertainment and maintenance.” -
MarketWatch - Business
I’m a retired cardiologist, 64, with a $9 million net worth. I want to buy my ‘forever home.’ How much should I spend?
“What is the maximum should I safely spend assuming I live into my 80s?” -
The Hill - Politics
We need more accountability in our politics — I’ll go first.
we’re a little over halfway through the year, so it’s time to take a look back at some of the good (and bad) predictions I made back in the frosty winter months of 2024. -
The Guardian - World
This is how we do it: ‘The sheep on our farm hinder our sex life more than the kids’
Friction in the fields is wreaking havoc in the bedroom for farmers and parents Rosie and Brian. How do you do it? Share the story of your sex life, anonymously. There is something hot about being a farmer, but working together is tricky – Brian ... -
MarketWatch - Business
‘Our children have varying degrees of success’: My husband and I are in our 80s and have $300,000 to leave our 3 kids. Do we give more to our underemployed son?
“At 56, he has few prospects for his future.” -
The Guardian - World
Our attitudes towards AI reveal how we really feel about human intelligence
We’re in the untenable position of regarding the AI as alien because we’re already in the position of alienating each other. The idea that superintelligent robots are alien invaders coming to “steal our jobs” reveals profound shortcomings in the ... -
The Guardian - World
‘We want our peace’: why is France’s far-right support such a rural affair?
Media rhetoric about migrants and crime is rallying support for the National Rally in the countryside but, say city folk, the reality is different. Flanked by fields of corn and tree-lined ponds, Colombier-Saugnieu has a proximity to the bustling ... -
ESPN - Sports
Healthy Kawhi 'having a good time' with Team USA
Speaking to reporters during Team USA's training camp in Las Vegas Sunday, LA Clippers star Kawhi Leonard said "I'm out here now and, yeah, I'm having a good time" after missing the final three games of his club's first-round exit with knee ... -
MarketWatch - Business
I’m in my 60s and mentored Gen Z students from NYU. This is what we taught each other.
Why mentoring in unretirement is great for you and young adults
More from MarketWatch
-
MarketWatch - Business
Momentus’s stock climbs, as space-services company is on pace to snap five-day losing streak
Shares of Momentus, which provides satellite transportation and servicing, jumped in premarket trades Monday. -
MarketWatch - Business
Devon Energy to pay $5 billion for unit of EnCap-backed Grayson Energy
Devon is buying acreage in the Williston Basin, an energy-rich area mostly in Montana, North Dakota and Saskatchewan.Energy -
MarketWatch - Business
‘He thinks I’m too materialistic’: My husband and I are in our 40s. He takes zero interest in our finances. He doesn’t even know the name of our mortgage company. What can I do?
“I am really worried that if I’m not around, he will not be able to manage the basics of everyday life for himself and our children.” -
MarketWatch - Business
Three reasons bulls should be stoic in the face of legitimate stock-market worries
Ed Yardeni offers three important reasons why investors should be less worried. -
MarketWatch - Business
Eli Lilly to pay $3.2 billion in cash to buy this biotech with an IBD treatment
Morphic’s stock rocketed Monday, after the biopharmaceutical company announced an agreement to be acquired by Eli Lilly in a cash deal valued at about $3.2 billion.